This topic contains a solution. Click here to go to the answer

Author Question: The protein(s) that are the major contributors to plasma osmolarity is/are A) globulins. B) ... (Read 97 times)

jho37

  • Hero Member
  • *****
  • Posts: 531
The protein(s) that are the major contributors to plasma osmolarity is/are
 A) globulins.
  B) albumins.
  C) fibrinogen.
  D) lipoprotein.
  E) transferrin.

Question 2

On a tour of African countries, Mark contracts a bad case of traveler's diarrhea. Because he can't eat very much, his body starts to use energy sources other than carbohydrates. This would result in all of the following, except
 A) increased levels of urea in the blood.
  B) ketosis and a decreased blood pH.
  C) increased gluconeogenesis in the liver.
  D) lipid metabolism.
  E) glycogenesis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Christopher

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

B

Answer to Question 2

E




jho37

  • Member
  • Posts: 531
Reply 2 on: Feb 28, 2019
:D TYSM


bdobbins

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library